{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:49:27Z","timestamp":1790660967828,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T00:00:00Z","timestamp":1444953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s13277-015-3272-y","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T06:14:40Z","timestamp":1444976080000},"page":"3817-3821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Interleukin-3 receptor \u03b1 chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy"],"prefix":"10.1007","volume":"37","author":[{"given":"Wen","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jine","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,16]]},"reference":[{"key":"3272_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0950-3536(11)80009-0","volume":"5","author":"B Lowenberg","year":"1992","unstructured":"Lowenberg B, Touw IP. Haemopoietic growth factors in acute myeloblastic and lymphoblastic leukaemia. Baillieres Clin Haematol. 1992;5:599\u2013618.","journal-title":"Baillieres Clin Haematol"},{"key":"3272_CR2","first-page":"1261","volume":"86","author":"L Munoz","year":"2001","unstructured":"Munoz L, Nomdedeu JF, Lopez O, Carnicer MJ, Bellido M, Aventin A, et al. Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica. 2001;86:1261\u20139.","journal-title":"Haematologica"},{"key":"3272_CR3","first-page":"98","volume":"15","author":"S Moretti","year":"2001","unstructured":"Moretti S, Lanza F, Dabusti M, Tieghi A, Campioni D, Dominici M, et al. Cd123 (interleukin 3 receptor alpha chain). J Biol Regul Homeost Agents. 2001;15:98\u2013100.","journal-title":"J Biol Regul Homeost Agents"},{"key":"3272_CR4","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood.V82.3.752.752","volume":"82","author":"N Sato","year":"1993","unstructured":"Sato N, Caux C, Kitamura T, Watanabe Y, Arai K, Banchereau J, et al. Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells. Blood. 1993;82:752\u201361.","journal-title":"Blood"},{"key":"3272_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.leu.2403224","volume":"18","author":"U Testa","year":"2004","unstructured":"Testa U, Riccioni R, Diverio D, Rossini A, Lo Coco F, Peschle C. Interleukin-3 receptor in acute leukemia. Leukemia. 2004;18:219\u201326.","journal-title":"Leukemia"},{"key":"3272_CR6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3324\/haematol.2008.000299","volume":"94","author":"M Djokic","year":"2009","unstructured":"Djokic M, Bjorklund E, Blennow E, Mazur J, Soderhall S, Porwit A. Overexpression of cd123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia. Haematologica. 2009;94:1016\u20139.","journal-title":"Haematologica"},{"key":"3272_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.20101459","volume":"208","author":"V Bigley","year":"2011","unstructured":"Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, McGovern N, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med. 2011;208:227\u201334.","journal-title":"J Exp Med"},{"key":"3272_CR8","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdllow","year":"2008","unstructured":"Swerdllow SH, Campo E, Harris NL. WHO classification of tumours of haematopoietic and lymphoid tissues. France: IARC Press; 2008."},{"key":"3272_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2004.10.008","volume":"98","author":"MC Bene","year":"2005","unstructured":"Bene MC. Immunophenotyping of acute leukaemias. Immunol Lett. 2005;98:9\u201321.","journal-title":"Immunol Lett"},{"key":"3272_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cyto.b.20368","volume":"74","author":"J Zheng","year":"2008","unstructured":"Zheng J, Wang X, Hu Y, Yang J, Liu J, He Y, et al. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China. Cytometry B Clin Cytom. 2008;74:25\u20139.","journal-title":"Cytometry B Clin Cytom"},{"key":"3272_CR11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/leu.2010.312","volume":"25","author":"MC Bene","year":"2011","unstructured":"Bene MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, et al. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia. 2011;25:567\u201374.","journal-title":"Leukemia"},{"key":"3272_CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO;2-H","volume":"38","author":"D Campana","year":"1999","unstructured":"Campana D, Coustan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry. 1999;38:139\u201352.","journal-title":"Cytometry"},{"key":"3272_CR13","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/sj.leu.2404349","volume":"20","author":"L Lhermitte","year":"2006","unstructured":"Lhermitte L, de Labarthe A, Dupret C, Lapillonne H, Millien C, Landman-Parker J, et al. Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy. Leukemia. 2006;20:1908\u201310.","journal-title":"Leukemia"},{"key":"3272_CR14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.leu.2401493","volume":"13","author":"WL Blalock","year":"1999","unstructured":"Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, et al. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs. Leukemia. 1999;13:1109\u201366.","journal-title":"Leukemia"},{"key":"3272_CR15","first-page":"28","volume":"90","author":"FM Uckun","year":"1997","unstructured":"Uckun FM, Sather HN, Gaynon PS, Arthur DC, Trigg ME, Tubergen DG, et al. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group. Blood. 1997;90:28\u201335.","journal-title":"Blood"},{"key":"3272_CR16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V92.3.795","volume":"92","author":"MC Putti","year":"1998","unstructured":"Putti MC, Rondelli R, Cocito MG, Arico M, Sainati L, Conter V, et al. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood. 1998;92:795\u2013801.","journal-title":"Blood"},{"key":"3272_CR17","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.1998.16.12.3768","volume":"16","author":"CH Pui","year":"1998","unstructured":"Pui CH, Rubnitz JE, Hancock ML, Downing JR, Raimondi SC, Rivera GK, et al. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol. 1998;16:3768\u201373.","journal-title":"J Clin Oncol"},{"key":"3272_CR18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-3-642-84895-7_24","volume":"131","author":"WD Ludwig","year":"1993","unstructured":"Ludwig WD, Harbott J, Bartram CR, Komischke B, Sperling C, Teichmann JV, et al. Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86. Recent Results Cancer Res. 1993;131:269\u201382.","journal-title":"Recent Results Cancer Res"},{"key":"3272_CR19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1521-6926(03)00087-2","volume":"16","author":"R Schabath","year":"2003","unstructured":"Schabath R, Ratei R, Ludwig WD. The prognostic significance of antigen expression in leukaemia. Best Pract Res Clin Haematol. 2003;16:613\u201328.","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3272-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3272-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3272-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3272-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T21:34:00Z","timestamp":1599687240000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3272-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,16]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3272"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3272-y","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,16]]}}}